PURPOSE: COPD limits exercise tolerance and impairs quality of life. The therapy is largely palliative, the key aim of treatment being to improve patients’ ability to perform their usual daily activities and increase of health related quality of life (HRQoL). An education program can play a role in improving ability to cope with illness and health status.
METHODS: 89 patients stage II, III and IV(GOLD 2003) under outpatient conditions were included in this study. 75 patients were randomized in to four groups according to methods of the education (individual or small group and with physical training program or alone) and control group (n=14)received the usual general advice. All patients underwent the following tests: pulmonary function test, 6-MWT, dyspnea score. A health related quality of life was measured by the MOC 36 –item Short Health Survey (SF-36) and the St. George's Respiratory Questionnaire (SGRQ). Measurements were carried on baseline, 1 month, 6 month and 1 year after education course. The main teaching items of the program were self-control and self-management of the disease.
RESULTS: HRQoL was improved in total four groups according to SF-36 and SGRQ examinations. SF-36 results are increasing SF, RE, MH in total four groups. FA was improved in groups with fitness program. RP, BP, GH were not changed after education course. SGRQ results are increasing symptoms in two groups with physical training program after 6 month. Activity was improved in total groups from 1 month after course, and saved in groups with physical training program only. Impact was increase in total groups, particularly in groups with individual education. We found a loss of positive influence of education course according to SF-36 and SGRQ by the end of year.
CONCLUSION: A self-management education program has increased HRQoL. The physical training program is a prolonging factor of the positive impact.
CLINICAL IMPLICATIONS: The patients can be taught these skills, thus contributing to the control of their chronic conditions and minimizing the impact of their disease, resulting in improved HRQoL.
DISCLOSURE: Svetlana Semenyuk, No Financial Disclosure Information; No Product/Research Disclosure Information